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Abstract
An adequate intake of vitamin B12 during pregnancy plays an important role in offspring neurodevelopment, potentially via
epigenetic processes. We used a two-step Mendelian randomization approach to assess whether DNA methylation plays a
mediating and causal role in associations between maternal vitamin B12 status and offspring’s cognition. Firstly, we esti-
mated the causal effect of maternal vitamin B12 levels on cord blood DNA methylation using the maternal FUT2 genotypes
rs492602:A>G and rs1047781:A>T as proxies for circulating vitamin B12 levels in the Avon Longitudinal Study of Parents and
Children (ALSPAC) and we tested the observed associations in a replication cohort. Secondly, we estimated the causal effect
of DNA methylation on IQ using the offspring genotype at sites close to the methylated CpG site as a proxy for DNA methyla-
tion in ALSPAC and in a replication sample. The first step Mendelian randomization estimated that maternal vitamin B12 had
a small causal effect on DNA methylation in offspring at three CpG sites, which was replicated for one of the sites. The second
step Mendelian randomization found weak evidence of a causal effect of DNA methylation at two of these sites on childhood
performance IQ which was replicated for one of the sites. The findings support a causal effect of maternal vitamin B12 levels
on cord blood DNA methylation, and a causal effect of vitamin B12-responsive DNA methylation changes on children’s cogni-
tion. Some limitations were identified and future studies using a similar approach should aim to overcome such issues.
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Introduction
Components of one carbon metabolism, which includes folate,
and several B vitamins, play an important role in prenatal nutri-
tion and have been implicated in a range of neurodevelopmen-
tal disorders in offspring (1). Periconceptional folic acid or
multivitamin supplementation has been shown to protect off-
spring against neural tube defects (2–6) and more recently folic
acid supplementation during pregnancy has been linked to re-
duced risk of severe language delay (7) and autism in children
(8). Adequate circulating vitamin B12 levels during pregnancy
are also associated with a decreased risk of neural tube defects
(9) and there is evidence that maternal vitamin B12 status during
pregnancy is associated with offspring cognition (10–13).
The mechanisms through which sub-optimal levels of circu-
lating vitamin B12 exert unfavourable effects during pregnancy
are not fully understood. One possible pathway is via the role of
vitamin B12 in one carbon metabolism and the donation of
methyl groups for the methylation of a range of biological mole-
cules including DNA. Profound changes in DNA methylation
which occur in early development in the brain and nervous sys-
tem may be particularly sensitive to vitamin B12 availability dur-
ing foetal life. Emerging evidence suggests that maternal
prenatal vitamin B12 status influences DNA methylation at the
insulin-like growth factor-II locus and at a global level (14–16).
A recurring problem in addressing questions of maternal
prenatal nutrition and offspring outcomes is distinguishing
causal relationships in the face of multiple potential confound-
ing factors. A Mendelian randomization (MR) approach has
been widely applied in an attempt to strengthen causal infer-
ence and circumvent the issue of confounding in such studies
(13,17–23). In a Mendelian randomization framework, a genetic
variant is used as a proxy for the exposure of interest. This ap-
proach can be implemented when considering vitamin B12 as an
exposure, as genetic variants have recently been reported that
are robustly associated with vitamin B12 levels. For example,
genome-wide association studies have identified common ge-
netic variants in the FUT2 gene to be associated with serum vi-
tamin B12 levels in individuals with European ancestry (24–27)
and in a Chinese population (28). Two FUT2 SNPs that are
strongly associated with vitamin B12 levels are rs492602:A>G
and rs1047781:A>T. In a previous study (13), maternal genotype
at the common single nucleotide polymorphism (SNP)
rs492602:A>G in the FUT2 gene was found to be associated
with offspring’s IQ at age 8. Since maternal FUT2 genotype is not
associated with socioeconomic confounders that might affect
maternal vitamin B12 levels and intake, these findings suggest
that maternal vitamin B12 levels are causally related to chil-
dren’s IQ but have little effect. These findings were not con-
firmed in more recent studies (29,30) and the intermediate
effect of DNA methylation has not been previously examined.
An extension of Mendelian randomization to investigate
mediation has been described (17,31), and the particular appli-
cation to epigenetic studies elaborated upon (17). The aim of
this method is to assess whether DNA methylation plays a me-
diating and causal role in linking an exposure to an outcome. In
‘two-step epigenetic Mendelian randomization’ a SNP is used to
proxy for the exposure of interest but rather than explore its as-
sociation with the phenotype of interest (here child IQ), DNA
methylation is considered as an outcome in the first step. If
DNA methylation variation is associated with the exposure,
then a second Mendelian randomization step can be applied us-
ing an SNP that proxies for methylation levels at the site modi-
fied by the exposure of interest, and its association with the
interrogated exposure. The process is summarised in Figure 1.
The rationale for this study is twofold. Firstly, based on indica-
tions in the literature that maternal vitamin B12 levels during
pregnancy affect cognitive neurodevelopment, we wanted to
address the biological question of whether epigenetic changes
play a role in this association. Secondly, we wanted to explore
and develop the recently established Mendelian randomization
methodology and apply it to a novel setting within the context
of mediation.
In this study, we investigated the potential mediating role of
DNA methylation in the observed relationship between mater-
nal prenatal vitamin B12 levels and offspring IQ using a two-step
epigenetic Mendelian randomization (MR) approach (17). In the
first step, we used maternal genetic variants at the FUT2 gene as
proxies for in utero vitamin B12 exposure on offspring DNA
methylation at the genome-wide level. Site-specific differences
in DNA methylation (CpG sites) identified in step 1 were taken
forward to step 2; in the second step we used offspring SNPs
near the CpGs of interest as proxies for offspring DNA methyla-
tion, and used these to estimate the causal effect of DNA meth-
ylation in children on their own IQ. If DNA methylation
mediates an association between prenatal vitamin B12 exposure
and IQ, we should observe firstly that the maternal FUT2 genetic
variation is associated with offspring DNA methylation and sec-
ondly that SNPs that proxy for the associated methylation sites
are associated with childhood IQ. The SNP effect on both the ex-
posure and the outcome might indicate causality or a pleiotro-
pic effect (the outcome and the exposure are affected by the
same SNP) as elucidated recently (22,32,33). Ideally, the out-
comes of both MR steps should be justified a-priori or based on
analyses in a separate dataset to avoid bias. However, because
available datasets are lacking and no previous studies have in-
vestigated DNA methylation as a mediator on the causal path-
way between maternal FUT2 genotype and childhood IQ, we
performed both steps in subgroups of the same study popula-
tion and tried to replicate the first and second step in separate
studies. This work has also highlighted other challenges associ-
ated with two-step Mendelian randomization that future stud-
ies should consider and attempt to overcome.
Results
A flow-chart summarizing the two-steps diagram including the
datasets used and relevant results tables is presented in
Figure 2.
Study sample characteristics
We performed the first and second step MR in the Avon
Longitudinal Study of Parents and Children (ALSPAC) study
(34,35). From the original eligible sample, only subsets of sub-
jects had the data needed for each analysis step (mother and
child genetic, epigenetic, IQ). The numbers of subjects included
in each different analysis are shown in the corresponding result
tables. Table 1 shows the characteristics of the study population
and of the subsamples used in the 1st–step MR and the 2nd–step
MR. The children that were participants in the first step MR
analysis had slightly older and better educated mothers who
smoked less than the children in the second step MR analysis.
The children of the first step MR analysis also were tested at a
slightly younger age on average and had higher IQ scores.
Mother’s BMI, parity and child’s sex did not seem to differ be-
tween the two study samples.
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The replication of the first step was carried out in the
Genetics of Overweight Young Adults (GOYA) study. The GOYA
study was similar to the ALSPAC in terms of age of delivery,
child’s sex and parity. However, BMI was higher, and there was
a higher proportion of pregnancy smokers and highly educated
mothers. The characteristics of the study populations are sum-
marized in Table 1.
1st–step MR. The association of maternal FUT2 genotype with
cord blood DNA methylation was explored by running a
methylome-wide association study (MWAS) in ALSPAC. The re-
sults are presented in Figure 3 and the top 20 CpGs with the low-
est P-values are reported in Tables 2 and 3. The MWAS for
mother’s rs492602:A>G genotype (genomic inflation factor
k¼ 0.969) did not show any CpG site where offspring DNA meth-
ylation was associated with the maternal FUT2 genotype at
FDR 0.05. The rs1047781:A>T MWAS (k¼ 0.802) revealed three
CpGs where offspring DNA methylation was associated with the
maternal FUT2 genotype at FDR 0.05. Maternal FUT2 genotype
was associated with lower DNA methylation at cg23332223 in
an intergenic region upstream the gene USP29 and it was associ-
ated with higher methylation at cg10543947 and cg15676719, at
the transcription start sites of the genes APOL2 and RCSD1.
These three CpG sites were carried forward in the first step MR
analysis.
GENOTYPE (IV)
EMOCTUOERUSOPXE
Maternal FUT2
Maternal vitamin B12
levels in pregnancy
Offspring DNA methylation
CONFOUNDERS
Offspring cis-SNP
Childhood IQ
GENOTYPE (IV)
EXPOSURE OUTCOME
Step 1 Step 2
CONFOUNDERS
Figure 1. Diagram showing the two-step Mendelian randomization approach used in this study. Step 1: The maternal FUT2 genotype is used as instrumental variable
(IV) for circulating vitamin B12 levels in pregnancy (exposure) as its effect on cord blood CpG methylation (outcome) is not vulnerable to confounders. Step 2: The off-
spring genotype at a cis-SNP around the CpG whose methylation is affected by maternal FUT2 genotype is used as IV for CpG methylation to estimate the effect of cord
blood methylation (exposure) on childhood IQ (outcome) as it is free from confounder biases.
Methylome-wide association study for maternal FUT2 in
ALSPAC-ARIES cord blood 450K data (N=641):
3 CpG sites at FDR<0.05 (Tables 2 and 3, Figure 3)
Cis-SNP discovery from publicly 
available  ALSPAC-ARIES data  
(N=771):
2 independent SNPs for 2 CpG sites at
p<1 x 10-7 (Table 5)
Two-sample IV analysis (Table 4)
STEP 1: 
Effect of 
maternal
vitamin B12 on
DNA 
methylation
STEP 2: 
Effect of DNA 
methylation on 
cognition
Cis-SNP to IQ regression in ALSPAC-
NON-ARIES (N=3354-3843)
(Table 6)
Two-sample IV analysis
(Table 6)
Identification of vitamin B12 FUT2 SNPs from GWAS
literature
Replication of the 3 CpG sites in GOYA
cord blood 450K data (N=916)
Two-sample IV analysis (Table 4)
Replication of 2 CpG sites using
publicly available SSGAC data
in MR-base
Two-sample IV analysis
(Table 7)
Observational
analysis in ALSPAC-
ARIES (N=611-608)
(Table 6)
Figure 2. Flow diagram showing the two steps of the analysis conducted.
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The two-sample MR analysis for the first step was performed
using the genotype-exposure estimates from the GWAS study
on vitamin B12 levels previously published by Lin et al. (28).
Specifically, beta coefficient¼ 70.21 (pg/ml) and standard er-
ror¼ 5.53 (pg/ml) were used. The results are reported in Table 4.
In line with the above results, maternal vitamin B12 levels were
associated with decreased cord blood methylation upstream
the gene USP29, and with higher cord blood methylation at
APOL2 and RCSD1. Our analysis estimated that 1 pg/ml higher
maternal vitamin B12 increased or decreased cord blood methyl-
ation by less than 1% at each site investigated.
In the GOYA cohort, the association of maternal FUT2 geno-
type at rs1047781:A>T was in the same direction for all the
three CpGs investigated. There was evidence of replication for
cg23332223 (P-value<Bonferroni 0.05) as shown in Table 4.
2nd–step MR. The second step MR was carried out in the
ALSPAC and using summary data from the Social Science
Genetic Association Consortium (SSGAC) (36–38). In order to
perform the second step MR we looked in the ARIES mQTL data-
base for cis-SNPs for the vitamin B12-responsive CpG sites dis-
covered in the first step. At birth, there were no SNPs associated
with cg23332223 DNA methylation, therefore we could not per-
form the second step MR for this CpG site. There were six SNPs
associated with DNA methylation at cg10543947, which were
not independent and, amongst these, only rs5750236:C>T had
data in the SSGAC database, therefore we used rs5750236:C>T
as IV in the 2nd-step MR for this CpG. For cg15676719, 91 SNPs
were associated with DNA methylation, and there was only one
independent cis-SNP, rs1890131:C>T, which was therefore
taken forward as IV in the 2nd step MR. The characteristics of
the chosen cis-SNP are reported in Table 5.
Table 6 shows the results of the associations of cis-SNP ge-
notype and DNA methylation at corresponding CpG sites with
children’s IQ in the ALSPAC sample after excluding the samples
Table 1. Characteristics of study populations in the ALSPAC sub-samples used in the first step MR and second step MR analyses and in the
GOYA sample
ALSPAC (ARIES) (First step MR) ALSPAC (NON-ARIES) (Second step MR) P-valuea GOYA (First step)
Continuous variables Mean SD N Mean SD N Mean SD N
Mother’s age at delivery (years) 29.33 4.36 641 29.19 4.57 3843 0.003 29.58 4.01 916
Mother’s BMI 22.78 0.14 641 22.93 0.06 3501 0.314 29.41 7.64 916
Child’s age at testing (years) 8.62 0.18 641 8.67 0.28 3501 <0.001 – – –
Total IQ 107.69 15.62 568 104.44 16.42 3843 <0.001 – – –
Verbal IQ 110.82 16.63 571 107.49 16.60 3843 0.005 – – –
Performance IQ 101.94 16.81 571 99.83 16.94 3843 <0.001 – – –
Categorical variables % N % N % N
Mother’s education (university level) 22.15 641 16.96 3095 0.001 49.78 916
Child’s sex (male) 47.41 599 49.36 3843 0.375 51.31 916
Parity (previous pregnancies) 51.17 641 53.12 3761 0.360 53.06 916
Smoking during pregnancy 12.79 641 18.42 3779 0.001 22.27 916
aP-values for ALSPAC (ARIES) vs ALSPAC non-ARIES were calculated using Student’s t test for continuous variables and v2 test for categorical variables.
BMI, body mass index.
Figure 3. Manhattan plots showing the results of the methylome-wide association study (MWAS) for maternal FUT2 genotype in cord blood in the Avon Longitudinal
Study of Parents and Children (ALSPAC), adjusted for batch, cell composition, child’s genotype, mother’s body mass index (BMI), mother’s education, mother’s age at
conception, smoking during pregnancy and parity.
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Table 2. Association of CpG methylation and maternal FUT2 rs492602:A>G genotype (n¼ 641)
CpG ba S.E.a P-value N FDR Bonferroni Gene Gene region Chr. Position
cg00468410 0.010 0.002 1.40E-06 604 0.656 0.656 6 20239552
cg10979567 0.007 0.001 1.35E-05 594 1 1 COL6A3 Body 2 238241642
cg21877220 0.002 0.000 1.96E-05 598 1 1 17 46695449
cg19701577 0.005 0.001 2.03E-05 589 1 1 HOXA5 3’UTR 7 27181418
cg08835103 0.002 0.000 2.15E-05 594 1 1 DBX1 Body 11 20178138
cg13895650 0.034 0.008 2.47E-05 606 1 1 TLE1 Body 9 84228185
cg10998227 0.013 0.003 2.56E-05 603 1 1 12 101108809
cg11808677 0.007 0.002 2.79E-05 597 1 1 USP5 TSS1500 12 6960079
CDCA3 Body
cg04053798 0.014 0.003 3.55E-05 606 1 1 SLC38A4 1st exon 12 47219705
5’UTR
cg11933375 0.002 0.000 3.63E-05 590 1 1 SLC38A7 5’UTR 16 58718466
cg10601234 0.007 0.002 3.67E-05 592 1 1 15 25523666
cg03993171 0.001 0.000 3.83E-05 598 1 1 SNORD50B TSS1500 6 86388501
SNORD50A TSS200
SNHG5
cg18116968 0.019 0.005 4.99E-05 604 1 1 7 25900668
cg00256155 0.002 0.001 5.12E-05 599 1 1 1 47915647
cg18222500 0.028 0.007 5.41E-05 604 1 1 RPH3AL Body 17 143285
cg06223926 0.023 0.006 5.55E-05 606 1 1 10 33626522
cg27049594 0.054 0.013 5.77E-05 606 1 1 OR8A1 TSS1500 11 124439146
cg24508713 0.017 0.004 5.79E-05 603 1 1 ZBTB12 TSS1500 6 31870783
cg07470532 0.017 0.004 6.08E-05 602 1 1 7 153442389
cg06571387 0.008 0.002 6.24E-05 604 1 1 HOXD12 TSS1500 2 176964101
ab coefficients and standard errors for association tests are calculated using linear regression with number of minor alleles at the rs492602:A>G SNP as independent
variable and CpG proportion methylation as dependent variable (beta-values), adjusted for offspring’s genotype, batch (surrogate variables), maternal age, maternal
body mass index, maternal smoking, maternal education, parity and estimated cell counts. The b coefficient is to be interpreted as the change in methylation propor-
tion per minor-allele count unit increase.
FDR, false discovery rate; Chr., chromosome.
Table 3. Association of CpG methylation and maternal FUT2 rs1047781:A>T genotype (n¼ 641)
CpG ba S.E.a P-value N FDR Bonferroni Gene Gene region Chr. Position
cg23332223 0.259 0.040 1.71E-10 606 8.03E-05 8.03E-05 19 57626946
cg10543947 0.241 0.045 1.22E-07 606 0.029 0.057 APOL2 TSS200, 1st exon, 5’UTR 22 36635882
cg15676719 0.170 0.033 3.18E-07 606 0.050 0.149 RCSD1 TSS1500 1 167598521
cg10886493 0.161 0.033 1.21E-06 548 0.113 0.565 HLA-A Body 6 29911036
cg11290181 0.100 0.020 1.21E-06 593 0.113 0.566 CDC42SE2 5’UTR 5 130604045
cg10466124 0.045 0.010 9.46E-06 597 0.574 1 HLA-DRB5 TSS1500 6 32498285
cg14992144 0.059 0.013 9.46E-06 600 0.574 1 GHRLOS Body 3 10334743
GHRL TSS200
cg21480902 0.057 0.013 9.80E-06 606 0.574 1 13 68682181
cg13582692 0.270 0.062 1.50E-05 606 0.703 1 NCRNA00171 Body 6 30022577
cg25868126 0.081 0.019 1.58E-05 584 0.703 1 TMEM177 3’UTR 2 120439606
cg08489349 0.187 0.043 1.65E-05 606 0.703 1 ELP2P Body 17 656181
GEMIN4 TSS1500
cg14830466 0.025 0.006 2.91E-05 603 1 1 CTH TSS1500 1 70876729
cg08194323 0.111 0.027 3.18E-05 606 1 1 NAPSA Body 19 50862004
cg16913250 0.192 0.046 3.61E-05 584 1 1 CTTNBP2 TSS1500 7 117513835
cg04549115 0.015 0.004 5.06E-05 598 1 1 RWDD1 TSS200 6 116892534
cg24201793 0.095 0.023 5.08E-05 605 1 1 MBOAT2 TSS1500 2 9144764
cg17624832 0.028 0.007 5.56E-05 593 1 1 NXN Body 17 862284
cg16121206 0.245 0.061 6.06E-05 606 1 1 APOL2 TSS200 22 36636055
cg20503907 0.096 0.024 6.40E-05 606 1 1 MICB Body 6 31474086
cg04934595 0.015 0.004 6.43E-05 585 1 1 17 81021419
ab coefficients and standard errors for association tests are calculated using linear regression with number of minor (T) alleles at the rs1047781:A>T SNP as indepen-
dent variable and CpG proportion methylation as dependent variable (beta-values), adjusted for offspring’s genotype, batch (surrogate variables), maternal age, mater-
nal body mass index, maternal smoking, maternal education, parity and estimated cell counts. The b coefficient is to be interpreted as the change in methylation
proportion per minor-allele count unit increase.
FDR, false discovery rate; Chr., chromosome.
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with methylation data as they were used for the discovery of
cis-SNPs associations with methylation. The estimates from the
conventional (non-IV) analyses between DNA methylation and
IQ had very large standard errors and high P-values. However,
using MR, there was some evidence for a minimal causal effect
of DNA methylation on increasing performance IQ at APOL2 and
decreasing overall IQ and performance IQ at RCSD1.
The two-sample analysis conducted in MR-base using the
SSGAC database (Table 7) provided some evidence for an in-
crease in childhood intelligence via DNA methylation at the
APOL2 gene. Neither methylation site was associated with cog-
nitive/educational outcomes in the larger study. Childhood in-
telligence data for RCSD1 were not available.
Functional characterization of the methylation sites
The relatively novel USP29 gene codes for a ubiquitin-specific
processing protease and it is involved in ubiquitin-dependent
protein catabolic processes and thiol-dependent ubiquitinyl hy-
drolase activity. Some evidence show a role in the repair of DNA
damage and cell survival (39). It is expressed mainly in the
testis, while virtually no expression was found in the brain. An
association with urate levels in European lean men is reported
in the GWAS Catalog (40). The APOL2 gene encodes for a cyto-
plasmatic protein that is involved in lipid transport and lipopro-
tein metabolic processes. It is expressed in most tissues,
including the brain and the pituitary gland. It is upregulated in
the prefrontal cortex of schizophrenic patients (41), and the
GWAS Catalog reports an association with non-diabetic end-
stage renal disease in African Americans (42). The RCSD1 gene
encodes for a protein involved in actin filament binding. It was
found to be expressed at minimal levels in the brain, while it
was highly expressed in EBV-transformed lymphocytes, lung,
muscle, small intestine, spleen and whole blood. No associa-
tions were found in OMIM or in the GWAS Catalog.
Hypothesis-free MR analysis of other potential health
outcomes
Within MR-Base we performed a hypothesis-free MR analysis of
the association of DNA methylation with the disease outcomes.
For the APOL2 variant there were 32 diseases with available
Table 4. Step 1: IV estimates of the causal effect of maternal vitamin B12 levels on cord blood CpG methylation
ALSPAC (N¼ 641) GOYA (N¼ 916)
CPG Label Gene IV estimatea S.E. P-value IV estimatea S.E. P-value
cg23332223 0.004 0.0006 7.17 x 109 0.0008 0.0003 0.006
cg10543947 APOL2 0.003 0.0007 7.97 x 107 0.0006 0.0006 0.358
cg15676719 RCSD1 0.002 0.0005 1.66 x 106 0.0005 0.0002 0.038
aChange in proportion methylation (unit is 100%) per one unit increase in maternal plasma vitamin B12 (pg/ml).
IV, instrumental variable.
Table 5. Independent cis-SNPs selected in ARIES as instrumental variable for FUT2-responsive CpG methylation in the 2nd-step MR
CpG Gene Chr. SNP MAF SNP Position ba S.E. P-value
cg10543947 APOL2 22 rs5750236:C>T 0.4312 36585162 0.26 0.04 7.28 x 1009
cg15676719 RCSD1 1 rs1890131:C>T 0.4044 167597473 0.44 0.04 1.36 x 1025
aThe b coefficient is to be interpreted as the change in methylation proportion (unit is 100%) per minor allele count unit increase.
MR, Mendelian randomization; Chr., chromosome, MAF; minor allele frequency.
Table 6. Step 2: Association of DNA methylation with IQ at age 8
CpG site Gene SNP Outcome SNP effect
(N¼ 3354
-3843)a
P-value Methylation
effect
(observational)
(N¼ 611–608)b
P-value Methylation
effect (IV)
(N¼ 3354
–3843)c
P-value Vitamin B12
effect via CpG
methylation
(10 pg/ml)d
cg10543947 APOL2 rs5750236:C>T Overall IQ 0.53 (0.40) 0.19 1.17 (7.36) 0.87 2.03 (1.58) 0.20 0.06
Verbal IQ 0.13 (0.41) 0.75 0.51 (7.71) 0.95 0.49 (1.57) 0.75 0.01
Performance IQ 0.91 (0.42) 0.03 0.44 (8.21) 0.96 3.46 (1.71) 0.04 0.10
cg15676719 RCSD1 rs1890131:C>T Overall IQ 0.82 (0.38) 0.03 1.59 (10.92) 0.88 1.87 (0.88) 0.03 0.03
Verbal IQ 0.53 (0.38) 0.16 4.86 (11.42) 0.67 1.23 (0.88) 0.17 0.02
Performance IQ 0.99 (0.39) 0.01 8.91 (12.16) 0.46 2.26 (0.92) 0.01 0.04
ab coefficients (S.E.) indicate the change in IQ score units per minor allele count.
bb coefficients (S.E.) indicate the change in IQ score units per methylation proportion (unit is 100%).
cIV estimates (S.E.) represent the change in IQ score units per methylation proportion (unit is 100%).
dThe effect of vitamin B12 on IQ score is calculated by multiplying the IV estimates of the second step MR by the IV estimates of the first step MR and it is to be inter-
preted as the change in IQ score units per 10 pg/ml maternal vitamin B12 increase via DNA methylation at the individual CpG site.
IV, instrumental variable.
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genotype. The analysis showed weak evidence of an association
with type 2 diabetes (b¼ 0.11, S.E.¼0.06, uncorrected P-val-
ue¼ 0.047) and coronary heart disease (b¼0.15, S.E.¼0.08,
uncorrected P-value¼ 0.05). For the RCSD1 variant there were 32
diseases with available genotype. The analysis revealed some
association with ulcerative colitis (b¼ 0.14, S.E.¼0.05, uncor-
rected P-value¼ 0.008) and inflammatory bowel disease
(b¼ 0.10, S.E.¼0.04, uncorrected P-value¼ 0.018). The full results
are in Supplementary Materials, Table S1 and S2.
Discussion
Increasing evidence suggests that DNA methylation is an inter-
mediate link between prenatal malnutrition and offspring’s
neurocognitive development (1,9,10,12,29,43,44). We used a
two-step Mendelian randomization (MR) approach to investi-
gate whether prenatal exposure to maternal vitamin B12 levels
is causally linked to offspring’s IQ at age 8 via changes in off-
spring’s DNA methylation. In the first MR step, we used mater-
nal genotype in the FUT2 gene at rs492602:A>G and at
rs1047781:A>T two genetic variants that are strongly associ-
ated with vitamin B12 levels to estimate the causal association
with DNA methylation. Our IV analysis suggests that maternal
vitamin B12 status is causally associated with small differences
in DNA methylation in the cord blood of offspring. In the second
MR step, we used the offspring genotype at cis-SNPs associated
with DNA methylation at the three CpG sites most strongly as-
sociated with maternal vitamin B12 (identified in the first step)
and estimated the causal association between DNA methylation
and IQ. The causal estimates for this association were positive
at one site and negative at another site, therefore not providing
enough evidence for a positive effect of increasing vitamin B12
levels prenatally on offspring intelligence. Some caution is war-
ranted because the CpG sites taken forward to the second step
were selected amongst those that were associated with the in-
strument from the first step (maternal FUT2 genotype), there-
fore a causal effect on DNA methylation was expected for these
sites and the causal effect estimates for the first step might be
overestimated through this procedure. The replication cohort
provided more evidence for the associations found in the first
step, at least for one site, but we could not take forward this site
to the second step. Moreover, the effect sizes were much
smaller than in the discovery cohort. We tried to replicate the
findings of the second step using two-sample MR in MR-base
where we used GWAS summary data on childhood intelligence,
cognitive performance and years of schooling and we replicated
a positive effect of DNA methylation at the APOL2 gene on child-
hood intelligence, while we could not replicate the negative ef-
fect at the RCSD1 gene. Overall, our study suggests a small
positive effect of prenatal vitamin B12 on child’s IQ through DNA
methylation. Moreover, DNA methylation at vitamin B12-re-
sponsive genes seemed to have an effect on other disease out-
comes as ulcerative colitis and irritable bowel disease, although
these results need further investigation. The approach taken in
this study highlighted several other shortcomings that are dis-
cussed below and should be considered when performing two-
step Mendelian randomization in future studies.
A possible confounder in Mendelian randomization is popu-
lation stratification, however the ALSPAC study is mostly repre-
sentative of white mother-child pairs since non-white mothers
constitute only 2.2% of the ALSPAC sample (33) and genotyping
and epigenotyping has been undertaken on mainly white
mother-child pairs. Moreover, we excluded mothers and chil-
dren that were classified “non-white”. The drawback of this ap-
proach is that the results are not generalizable to non-white or
more mixed populations.
One typical limitation to consider in Mendelian randomiza-
tion studies is often the low power due to a small genetic effect
on the exposure. This is even more of a consideration in two
step MR where numbers need to be an order of magnitude
greater to account for the power needed at each stage. In the
first step, our study had 80% power to detect at true effect size
f2¼0.01 of maternal FUT2 on DNA methylation at a¼ 0.05/485000
and n¼ 641. The first step two-sample analysis in ALSPAC had
80% power to detect a true standardized causal effect b¼ 0.52 at
R2¼0.05, a¼ 0.05 and n¼ 641 (online calculator https://sb452.shi
nyapps.io/power/; date last accessed May 03, 2017) (45). Our
findings in ALSPAC were still largely underpowered due to the
low minor allele frequency of FUT2 genotype and due to the
small effect sizes therefore we tried to overcome this by running
the 1st step MR in a separate cohort, where we had 80% power to
detect a true effect b¼ 0.42 at R2¼0.05, a¼ 0.05 and n¼ 916. Since
we focused our investigation on the top CpG sites resulting
from the methylome-wide association analysis, we may have
missed sites with weaker association with FUT2 that could po-
tentially still be associated with IQ. The 450K data set contains
probes for only around 1% of the CpGs that are potentially
methylated in the whole genome. However, more informative
technologies such as sequencing are not yet affordable for large
sample sizes from population studies. In the second step, we
had 80% power to detect cis-SNPs for cord blood DNA methyla-
tion at a true effect size f2¼0.01 at a¼ 0.05/6000000 and n¼ 770.
Table 7. IV estimates of the effect of DNA methylation at birth on cognition and educational attainment
CpG site SNP Outcome N ba S.E.a P-value
cg10543947 rs5750236:C>T Childhood intelligence 12,441 0.145 0.062 0.019
rs5750236:C>T Cognitive performance 106,736 0.007 0.020 0.740
rs5750236:C>T College completion 126,559 0.025 0.046 0.592
rs5750236:C>T Years of schooling 126,559 0.006 0.015 0.689
cg15676719b rs1890131:C>T Cognitive performance 106,736 0.016 0.010 0.110
rs1890131:C>T College completion 126,559 0.007 0.023 0.765
rs1890131:C>T Years of schooling 126,559 0.014 0.009 0.134
abs and standard errors (S.E.) were calculated using the online tool MR-base which used data from the ARIES project (genotype-methylation) and the SSGAC consortium
(methylation-outcome) and are to be interpreted as a change in cognitive performance, college completion and years of schooling (standardized scores) per proportion
methylation unit.
bChildhood intelligence data were not available for this SNP.
IV, instrumental variable.
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Using those cis-SNPs in the two-sample MR allowed us to detect
true standardized causal effects b¼ 0.45 at 80% power, a¼ 0.05
and n¼ 3843. Therefore, we tested the 2nd step MR additionally
in a larger consortium, where we had 80% power to detect a
causal effect b¼ 0.025 at a¼ 0.05 and n¼ 12441. Moreover, only
two out of three CpG sites had independent SNPs and therefore
there is a need to identify cis-SNPs in larger datasets.
Another limitation of Mendelian randomization relevant to
our study is the potential for confounding due to pleiotropy and
linkage disequilibrium (LD). An on-line search on the GWAS
Catalog (46) has revealed that FUT2 is associated with pheno-
types such as obesity-related traits, Crohn’s disease, cholesterol
levels and bipolar disorder. These phenotypes might be down-
stream to the effects on vitamin B12 levels (vertical pleiotropy)
and therefore they might not represent a problem in the inter-
pretation of the Mendelian randomization analysis. However,
as the molecular biology of FUT2 is still unclear in relation to vi-
tamin B12, we cannot exclude potential biological pathways
that do not involve vitamin B12 (horizontal pleiotropy).
A hypothesis-free look-up in MR-base of all available traits and
outcomes identified associations of rs492602:A>G FUT2 geno-
type with Crohn’s disease, cholesterol levels, inflammatory
bowel disease and type 1 diabetes, but no associations for
rs1047781:A>T FUT2 genotype, the SNP on which our findings
are based. A future study could combine multiple genetic vari-
ants to proxy for vitamin B12 in order to overcome pleiotropy. In
the second step, we used independent cis-SNPs for methylation,
as these may be less likely to have pleiotropic effects and LD-
induced confounding than trans-SNPs. However, the children’s
genotype at the methylation sites showed some weak associa-
tion with phenotypes that are also affected by FUT2, suggesting
some potential pleiotropy perhaps in relation to their own FUT2
genotype.
Although blood is relatively easy to access in large popula-
tion studies, epigenetic marks are often tissue-specific, so stron-
ger associations might have been found in central nervous
system tissue. Although this is a potential limitation, obvious
ethical and logistical reasons precluded us from using such tis-
sue in this study and the relevance of these findings in blood
must be carefully considered. Some studies have suggested lit-
tle overlap between blood and brain DNA methylation patterns
(47,48) and some associations between blood DNA methylation
and brain-related processes, for instance with the functionality
of the serotonin pathway (49), childhood physical aggressive-
ness (50), major depressive disorder (51), autistic spectrum dis-
order (52) and schizophrenia (53). However, the concordance is
highly heterogeneous between different loci and can be mini-
mal (54–56). Regarding our specific findings, a publicly available
dataset (http://epigenetics.essex.ac.uk/bloodbrain/; date last
accessed May 03, 2017) (47) show some correlation between
adult brain and blood in two out of the three vitamin-B12 re-
sponsive CpGs (Supplementary Material, Fig. S1), the sites that
we took forward in step 2 MR (for cg15676719 the correlation is
for one brain area only). At this stage, it is still not possible to
know whether blood and brain correspondence translates into
similar effects from the maternal exposure to vitamin B12 and
this issue clearly requires further investigation.
Finally, the two-sample IV approach can be cost-effective,
especially when gene-exposure association estimates from large
GWAS studies are available (45). However, it assumes that the
two independent samples are comparable. The published study
we used is based on Chinese men. The SNP rs1047781:A>T used
as IV for prenatal vitamin B12 exposure seems to be a specific
SNP for Chinese populations (MAF¼ 0.459) and it is rare in the
ARIES (MAF¼ 0.004) and in the GOYA mothers (MAF¼ .009) that
participated in this study. The difference in the MAF between the
two samples might create a bias in the IV estimate. Data on the
association between vitamin B12 and FUT2 genotype in pregnant
women are lacking and there is to date no indication that hor-
monal changes affect the association between FUT2 genotype
and vitamin B12 levels. In a small subset of ALSPAC we found evi-
dence for a positive association only for child’s rs492602:A>G ge-
notype, (Supplementary Material, Table S1) and it remained after
adjusting for maternal genotype. Furthermore, although there is
evidence for a correlation between maternal and cord vitamin
B12 status (57), there is also evidence suggesting that maternal
vitamin B12 deficiency might not translate into a foetal vitamin
B12 deficiency (58). Consequently, impaired vitamin B12 levels in
the mothers might affect foetal DNA methylation through mech-
anisms other than lowering foetal vitamin B12 levels that have
yet to be explored.
To our knowledge, this is the first report of a methylome-
wide study of the effects of maternal prenatal vitamin B12 on
cord blood DNA methylation. Previous studies showed that ma-
ternal vitamin B12 levels were associated with cord blood hypo-
methylation of the promoter of the IGF2 gene (15) and overall
hypomethylation of genomic DNA (14). Another study found no
association with cord blood LINE-1 methylation (16). Other stud-
ies have found that maternal levels of other components of the
one-carbon metabolism affect cord blood DNA methylation
(43,59). Together with these other studies, our data suggest that
during pregnancy an adequate intake of micronutrients in-
volved in one-carbon pathway could affect DNA methylation.
With regards to cognitive development, the association found
in our study with APOL2 methylation in the blood might reflect
changes in lipid transport and metabolism in the brain that in
turn alter brain functioning and cognition (60). The hypothesis-
free analysis performed to extend the question to a wider range
of health consequences suggests causal effects beyond the cog-
nitive phenotype.
In conclusion, we applied a two-step Mendelian randomiza-
tion approach to investigate DNA methylation as a mediator be-
tween a prenatal exposure and a childhood outcome. We found
some evidence of a causal effect of maternal vitamin B12 levels
on cord blood DNA methylation and little evidence of a causal
effect of DNA methylation on childhood intelligence. This work
has highlighted the various strengths and particular challenges
associated with two-step Mendelian randomization and we
hope that it will motivate further use of the approach in similar
contexts where DNA methylation is hypothesised to mediate
observed associations between a prenatal exposure and a later-
life phenotype.
Materials and Methods
ALSPAC data
The subjects for the main part of this study were participants of
the ALSPAC (see for details (34,35). The participants included in
the study were from the core sample, singletons, and of white
ethnicity. Please note that the study website contains details of
all the data that is available through a fully searchable data dic-
tionary (http://www.bris.ac.uk/alspac/researchers/data-access/
data-dictionary/; date last accessed May 03, 2017). Ethical ap-
proval for the study was obtained from the ALSPAC Ethics and
Law Committee and the Local Research Ethics Committees.
Mothers’ and children’s genetic data at specified SNPs (see be-
low) were extracted from the ALSPAC GWAS database (34).
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Briefly, the genetic data for mothers (FUT2 genotype) were gener-
ated using the Illumina human660W-quad and the
IlluminaGenomeStudio calling algorithm. Quality Control mea-
sures included the removal of SNPs with more than 5% of miss-
ingness, a Hardy-Weinberg-Equilibrium P-value lower than 106
and a minor allele frequency on less than 1%. Samples with more
than 5% missingness, indeterminate X chromosome heterozygos-
ity or extreme autosomal heterozygosity were excluded. SNP im-
putation was carried out against the 1000 Genome Project
database (www.1000genomes.org; date last accessed May 03,
2017) (61). Genetic data for the children were generated by Sample
Logistics and Genotyping Facilities at the Wellcome Trust Sanger
Institute and LabCorp (Laboratory Corportation of America) using
support from 23andMe using the Illumina Human Hap 550-quad
and the Illumina GenomeStudio calling algorithm. Quality control
and imputation were performed as above.
Neonatal blood DNA methylation data were generated using
the IlluminaHumanMethylation450 BeadChip as part of the ARIES
project (http://www.ariesepigenomics.org.uk; date last accessed
May 03, 2017 (62)), where DNA methylation was measured in white
cells extracted from cord blood (82% of the subjects) and in cord
blood spots (18% of the subjects) and using the Illumina Infinium
450K platform. Briefly, DNA samples were bisulphite converted us-
ing the Zymo EZ DNA methylationTM kit (Zymo, Irvine, CA).
Following conversion genome-wide methylation was measured
using the Illumina HumanMethylation450 (HM450K) BeadChip.
The arrays were scanned using an Illumina iScan, with initial qual-
ity review using GenomeStudio. For each sample the proportion of
DNA molecules methylated at each CpG site is represented as a
beta-value (63). Samples with>20% probes with P-value >¼ 0.01
were excluded from further analysis and scheduled for repeat as-
say. Genotype probes on the HM450k were compared between
samples from the same individual and against SNP-chip data to
identify and remove any sample mismatches. Methylation data
were normalised with the wateRmelon R package (64), using the
“Tost” algorithm to reduce the non-biological differences between
probes (65). All the processing of the methylation data was done
using the meffil R package (available at https://github.com/per
ishky/meffil; date last accessed May 03, 2017).
After excluding multiple births, genetic data were available
for n¼ 8890 mothers and n¼ 8871 children whereas epigenetic
data were available for n¼ 914 children. The complete-cases sam-
ple containing genetic (mother and children), epigenetic and co-
variate data used for the MWAS (first step MR) was n¼ 641.
Childhood cognition was measured as the overall intelli-
gence score (IQ) derived from a shortened version of the
Wechsler Intelligence Scale for Children (WISC-III) that was ad-
ministered to the children at approximately 8 years of age
(66,67). The Verbal IQ score was computed using the age-scaled
scores obtained by administering the Information, Similarities,
Arithmetic, Vocabulary and Comprehension subtests. The
Performance IQ score is composed of the age-scaled scores of
Picture Completion, Coding, Picture Arrangement, Block Design
and Object Assembly subtests. IQ data were available from
n¼ 5164 children. Amongst these, n¼ 611 participants had epi-
genetic data and the relevant covariates and were used for the
conventional (non-IV analysis), whereas n¼ 3843 that did not
include the ones with epigenetic data were used for the IV anal-
ysis (second step MR).
Replication data
The subjects for the replication study of the first step MR were
participants in the GOYA Study which is described previously
by Paternoster et al. (68). It is based on the Danish National Birth
Cohort (69) and included 2451 women that were pregnant dur-
ing 1996–2002, had given birth to a live born infant, had pro-
vided a blood sample during pregnancy and had a BMI that
ranged from 32.6 to 64.4 and 2450 pregnant women during the
same period that were chosen at random. Of these, 1,960 ex-
tremely overweight and 1,948 control women were genotyped
using the Illumina Human610-Quad v1.0 BeadChip and passed
quality control. Cord blood DNA methylation data were gener-
ated for the offspring of 1000 mothers in the GOYA study. Cord
blood was collected according to standard procedures, spun and
frozen at 80˚C. DNA methylation analysis and data pre-
processing were performed at the University of Bristol using the
same protocol as for the generation of the ARIES (ALSPAC) data.
The complete-case sample was n¼ 916.
The replication of the second step MR was carried out us-
ing summary data from published studies that were carried out
by the Social Science Genetic Association Consortium (SSGAC)
(36–38).
Two-step MR analyses
Two-step Mendelian randomization analysis (Fig. 1) was per-
formed using instrumental variable (IV) analysis. For each step,
the IV estimator was calculated as the ratio between the b coef-
ficient of the genotype-outcome regression and the b coefficient
of the genotype-exposure regression. The standard error was
calculated as reported in Thomas et al., 2007 (70).
1st–step MR: Examining the causal effect of maternal vitamin B12
on DNA methylation. We first evaluated the association between
the genotype-outcome (FUT2-methylation) association in the
ALSPAC-ARIES study by conducting a methylome-wide associa-
tion study (MWAS) using the CpGassoc R package (71). Briefly,
after removing probes on sex chromosomes and probes with P-
value> 0.05, and after removing outliers, a linear regression
model measured the additive effect of the minor allele in the
maternal genotype at the rs492602:A>G SNP and at the
rs1047781:A>T in the FUT2 gene on DNA methylation at
468,622 CpG sites in cord blood. Batch (10 surrogate variables),
cell composition estimated for cord blood as in Bakulski et al.,
(72), child’s genotype, mother’s BMI, mother’s education, moth-
er’s age at conception, smoking during pregnancy and parity
were included in the model as covariates as they could poten-
tially influence DNA methylation at birth and therefore they
could potentially lead to errors in the phenotype assessment.
The three CpG sites observed to be most strongly associated
with maternal FUT2 based on the MWAS (false discovery rate,
FDR,0.05) were taken forward in the IV analysis, which esti-
mated the causal exposure-outcome relationship, i.e. the causal
effect of maternal vitamin B12 levels on offspring DNA methyla-
tion. We then tested the top three FUT2-CpG associations using
the genetic and epigenetic data from the GOYA cohort. For this
analysis, we followed the same samples and probes exclusions
and statistical models as for the ALSPAC cohort, including the
same covariates.
Functional analyses for the methylation genome-wide sig-
nificance hits were carried out using online tools. A search for
functional annotation terms was performed using the Gene
Ontology Consortium website (www.geneontology.org; date last
accessed May 03, 2017) (73). Gene expression was examined in
the Genotype-Tissue Expression (GTEx) portal version V6p
(www.gtexportal.org; date last accessed May 03, 2017). A litera-
ture search for potential associations with health phenotypes
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was performed using the NHGRI-EBI GWAS Catalog of published
genome-wide association studies (www.ebi.ac.uk/gwas/; date
last accessed May 03, 2017) (46) and the Online Mendelian
Inheritance in Man (OMIM) database (www.omim.org; date last
accessed May 03, 2017).
2nd–step MR: Examining the causal effect of DNA methylation on
IQ. Firstly, conventional (non-IV) linear regression analysis was
performed to assess the association between DNA methylation
(the exposure) and IQ (the outcome) in the ALSPAC cohort.
These analyses were carried out using beta-values for each of
the CpG sites identified as associated with maternal FUT2 in
step 1. Models were adjusted for age of testing batch (surrogate
variables), mother’s BMI, mother’s age at delivery, mother’s ed-
ucation, smoking during pregnancy, and parity.
Next, Mendelian randomization was used to estimate the
causal association between DNA methylation and IQ. For the
methylation probes discovered in step 1, cis-SNPs were identi-
fied in the mQTL database (http://mqtldb.org; date last accessed
May 03, 2017) (74), which contains the associations between
CPG methylation and SNPs observed in the ARIES project at
P< 107. These were SNPs associated with CpG methylation and
were located within 1 Mb either side of the CpG. Independent
cis-SNPs, obtained through LD clumping, were selected as the
instrumental variables for CpG methylation and the b coeffi-
cient and standard error for the cis-SNP-methylation associa-
tion were used in the IV analysis. The sample size for this
analysis was n¼ 770.
For the genotype-outcome associations, IQ was regressed on
the cis-SNPs in the ALSPAC cohort, excluding participants that
were used to identify cis-SNPs, as it has been shown that choos-
ing variants according to their strength of association with ex-
posure in the data under analysis can give biased estimates
(75,76). The models included age of testing as a covariate.
The 2nd–step MR was also run in a separate study in order to
investigate replication and benefit from the increased power of a
larger study sample. A two-sample MR was carried out using
MRbase (http://www.mrbase.org/beta/; date last accessed May 03,
2017), an online platform that contains data from 985 genome-
wide association studies and interfaces with the R package
TwoSampleMR (https://github.com/MRCIEU/TwoSampleMR; date
last accessed May 03, 2017). Cognitive and education genome-
wide association data were available from the Social Science
Genetic Association Consortium (SSGAC) (36–38). We selected
childhood intelligence, cognitive performance, college comple-
tion and years of schooling as outcomes.
Supplementary Material
Supplementary Material is available at HMG online.
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